Chris Lai, founder and CEO of METiS Therapeutics

Transpa­cif­ic AI biotech makes its Se­ries A de­but — putting $86M in the bank

With the rush of AI per­me­at­ing the biotech in­dus­try, an­oth­er AI play­er is com­ing out well-or­ga­nized and flush with cash. METiS Ther­a­peu­tics an­nounced this morn­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.